Neuromodulation Devices Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

Neuromodulation devices are advanced therapeutic tools that use electrical stimulation to manage neurological conditions like Parkinson’s disease, epilepsy, chronic pain, and depression, available as spinal cord stimulators (SCS), deep brain stimulators (DBS), sacral nerve stimulators, vagus nerve stimulators (VNS), gastric electrical stimulators, and others.

These devices are employed in hospitals, ambulatory surgery centers (ASCs), clinics, physiotherapy centers, and other settings. The market is driven by the rising prevalence of neurological disorders, with WHO data indicating 50 million people affected by epilepsy and 10 million by Parkinson’s disease. The preference for low-risk, non-invasive treatments and approximately 200,000 annual DBS procedures globally further propel demand.

Market Size and Growth Forecast

The global neuromodulation devices market is projected to reach between USD 3.1 billion and USD 5.3 billion in 2025, with a compound annual growth rate (CAGR) of 6.8% to 9.1% through 2030, reflecting disease prevalence and technological advancements.

Regional Analysis

North America: The U.S. leads with high adoption of DBS and SCS, while Canada focuses on chronic pain management.
Europe: Germany, France, and the UK dominate, driven by aging populations and neurological care.
Asia Pacific: China and India see rapid growth due to rising neurological disorders, while Japan prioritizes elderly solutions.
Rest of the World: Brazil expands neuromodulation access, and the Middle East, notably the UAE, invests in advanced therapies.

Application Analysis

Hospitals & Ambulatory Surgery Centers (ASCs): Expected growth of 6.5-8.8%, driven by complex procedures. Trends focus on closed-loop systems.
Clinics & Physiotherapy Centers: Projected growth of 7.0-9.5%, linked to outpatient therapies. Developments emphasize portability.
Others: Anticipated growth of 6.2-8.5%, including home use. Advances prioritize patient accessibility.

Type Analysis

Spinal Cord Stimulators: Expected growth of 7.0-9.2%, valued for chronic pain relief. Trends focus on wireless designs.
Deep Brain Stimulators: Projected growth of 6.8-9.0%, key for Parkinson’s and epilepsy. Advances highlight adaptive stimulation.
Sacral Nerve Stimulators: Anticipated growth of 6.5-8.8%, suited for incontinence. Developments prioritize miniaturization.
Vagus Nerve Stimulators: Expected growth of 7.2-9.5%, driven by epilepsy and depression. Trends focus on non-invasive options.
Gastric Electrical Stimulation: Projected growth of 6.0-8.5%, key for gastroparesis. Advances highlight efficacy.
Others: Anticipated growth of 6.5-9.0%, including TMS. Developments emphasize innovation.

Key Market Players

Leading firms include Medtronic, offering advanced stimulators; Boston Scientific Corporation, enhancing pain management; Abbott, improving DBS technology; Nevro Corporation, specializing in SCS; Saluda Medical, innovating in closed-loop systems; Nexstim, focusing on TMS; LivaNova, targeting VNS; Neuropace, advancing epilepsy care; ElectroCore, enhancing non-invasive options; and Axonics, improving sacral stimulation. These companies drive market growth through innovation.

Porter's Five Forces Analysis

Threat of New Entrants: Moderate, due to high R&D costs and regulatory barriers, though niche players can enter with innovative designs.
Threat of Substitutes: Moderate, with pharmaceuticals competing, though devices offer unique long-term benefits.
Bargaining Power of Buyers: Moderate, with hospitals seeking cost-effective, high-efficacy devices while balancing patient outcomes.
Bargaining Power of Suppliers: Low, due to multiple component suppliers, reducing dependency risks.
Competitive Rivalry: High, with firms competing on stimulation precision, device size, and patient monitoring.

Market Opportunities and Challenges

Opportunities

Epilepsy affecting 50 million and Parkinson’s 10 million people globally highlight the need for neuromodulation devices.
An aging population, projected to reach 2.1 billion over 60 by 2050, increases neurodegenerative disease prevalence.
Approximately 200,000 annual DBS surgeries boost adoption.
Innovations like Medtronic’s Percept and Nevro’s HF10 enhance efficacy, while emerging markets offer growth as healthcare access improves.

Challenges

High costs of advanced devices limit adoption in low-income regions.
Regulatory delays for novel technologies slow market entry.
Reimbursement variability across regions affects penetration.
Market News
In July 2024, Mainstay Medical received approvals for its ReActiv8 system for full-body MRI compatibility.
In February 2024, Boston Scientific gained FDA approval for the WaveWriter SCS for non-surgical back pain.
In January 2024, Abbott launched the Liberta RC DBS, the smallest rechargeable DBS device.
In November 2023, Nevro acquired Vyrsa Technologies, enhancing SI joint pain solutions.

This product will be delivered within 1-3 business days.

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms

Chapter 3 Preface

3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method

Chapter 4 Market Landscape

4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

Chapter 5 Market Trend Analysis

5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats

Chapter 6 Industry Chain Analysis

6.1 Upstream/Suppliers Analysis
6.2 Neuromodulation Devices Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

Chapter 7 Latest Market Dynamics

7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

Chapter 8 Historical and Forecast Neuromodulation Devices Market in North America (2020-2030)

8.1 Neuromodulation Devices Market Size
8.2 Neuromodulation Devices Market by End Use
8.3 Competition by Players/Suppliers
8.4 Neuromodulation Devices Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico

Chapter 9 Historical and Forecast Neuromodulation Devices Market in South America (2020-2030)

9.1 Neuromodulation Devices Market Size
9.2 Neuromodulation Devices Market by End Use
9.3 Competition by Players/Suppliers
9.4 Neuromodulation Devices Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru

Chapter 10 Historical and Forecast Neuromodulation Devices Market in Asia & Pacific (2020-2030)

10.1 Neuromodulation Devices Market Size
10.2 Neuromodulation Devices Market by End Use
10.3 Competition by Players/Suppliers
10.4 Neuromodulation Devices Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia

Chapter 11 Historical and Forecast Neuromodulation Devices Market in Europe (2020-2030)

11.1 Neuromodulation Devices Market Size
11.2 Neuromodulation Devices Market by End Use
11.3 Competition by Players/Suppliers
11.4 Neuromodulation Devices Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia

Chapter 12 Historical and Forecast Neuromodulation Devices Market in MEA (2020-2030)

12.1 Neuromodulation Devices Market Size
12.2 Neuromodulation Devices Market by End Use
12.3 Competition by Players/Suppliers
12.4 Neuromodulation Devices Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey

Chapter 13 Summary For Global Neuromodulation Devices Market (2020-2025)

13.1 Neuromodulation Devices Market Size
13.2 Neuromodulation Devices Market by End Use
13.3 Competition by Players/Suppliers
13.4 Neuromodulation Devices Market Size by Type

Chapter 14 Global Neuromodulation Devices Market Forecast (2025-2030)

14.1 Neuromodulation Devices Market Size Forecast
14.2 Neuromodulation Devices Application Forecast
14.3 Competition by Players/Suppliers
14.4 Neuromodulation Devices Type Forecast

Chapter 15 Analysis of Global Key Vendors

15.1 Medtronic
15.1.1 Company Profile
15.1.2 Main Business and Neuromodulation Devices Information
15.1.3 SWOT Analysis of Medtronic
15.1.4 Medtronic Neuromodulation Devices Revenue, Gross Margin and Market Share (2020-2025)
15.2 Boston Scientific Corporation
15.2.1 Company Profile
15.2.2 Main Business and Neuromodulation Devices Information
15.2.3 SWOT Analysis of Boston Scientific Corporation
15.2.4 Boston Scientific Corporation Neuromodulation Devices Revenue, Gross Margin and Market Share (2020-2025)
15.3 Abbott
15.3.1 Company Profile
15.3.2 Main Business and Neuromodulation Devices Information
15.3.3 SWOT Analysis of Abbott
15.3.4 Abbott Neuromodulation Devices Revenue, Gross Margin and Market Share (2020-2025)
15.4 Nevro Corporation
15.4.1 Company Profile
15.4.2 Main Business and Neuromodulation Devices Information
15.4.3 SWOT Analysis of Nevro Corporation
15.4.4 Nevro Corporation Neuromodulation Devices Revenue, Gross Margin and Market Share (2020-2025)
15.5 Saluda Medical
15.5.1 Company Profile
15.5.2 Main Business and Neuromodulation Devices Information
15.5.3 SWOT Analysis of Saluda Medical
15.5.4 Saluda Medical Neuromodulation Devices Revenue, Gross Margin and Market Share (2020-2025)
15.6 Nexstim
15.6.1 Company Profile
15.6.2 Main Business and Neuromodulation Devices Information
15.6.3 SWOT Analysis of Nexstim
15.6.4 Nexstim Neuromodulation Devices Revenue, Gross Margin and Market Share (2020-2025)
15.7 LivaNova
15.7.1 Company Profile
15.7.2 Main Business and Neuromodulation Devices Information
15.7.3 SWOT Analysis of LivaNova
15.7.4 LivaNova Neuromodulation Devices Revenue, Gross Margin and Market Share (2020-2025)
15.8 Neuropace
15.8.1 Company Profile
15.8.2 Main Business and Neuromodulation Devices Information
15.8.3 SWOT Analysis of Neuropace
15.8.4 Neuropace Neuromodulation Devices Revenue, Gross Margin and Market Share (2020-2025)
15.9 ElectroCore
15.9.1 Company Profile
15.9.2 Main Business and Neuromodulation Devices Information
15.9.3 SWOT Analysis of ElectroCore
15.9.4 ElectroCore Neuromodulation Devices Revenue, Gross Margin and Market Share (2020-2025)
15.10 Axonics
15.10.1 Company Profile
15.10.2 Main Business and Neuromodulation Devices Information
15.10.3 SWOT Analysis of Axonics
15.10.4 Axonics Neuromodulation Devices Revenue, Gross Margin and Market Share (2020-2025)
15.11 Laborie
15.11.1 Company Profile
15.11.2 Main Business and Neuromodulation Devices Information
15.11.3 SWOT Analysis of Laborie
15.11.4 Laborie Neuromodulation Devices Revenue, Gross Margin and Market Share (2020-2025)
15.12 Mainstay Medical
15.12.1 Company Profile
15.12.2 Main Business and Neuromodulation Devices Information
15.12.3 SWOT Analysis of Mainstay Medical
15.12.4 Mainstay Medical Neuromodulation Devices Revenue, Gross Margin and Market Share (2020-2025)

List of Tables and Figures

Table Abbreviation and Acronyms
Table Research Scope of Neuromodulation Devices Report
Table Data Sources of Neuromodulation Devices Report
Table Major Assumptions of Neuromodulation Devices Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Neuromodulation Devices Picture
Table Neuromodulation Devices Classification
Table Neuromodulation Devices Applications
Table Drivers of Neuromodulation Devices Market
Table Restraints of Neuromodulation Devices Market
Table Opportunities of Neuromodulation Devices Market
Table Threats of Neuromodulation Devices Market
Table COVID-19 Impact For Neuromodulation Devices Market
Table Raw Materials Suppliers
Table Different Production Methods of Neuromodulation Devices
Table Cost Structure Analysis of Neuromodulation Devices
Table Key End Users
Table Latest News of Neuromodulation Devices Market
Table Merger and Acquisition
Table Planned/Future Project of Neuromodulation Devices Market
Table Policy of Neuromodulation Devices Market
Table 2020-2030 North America Neuromodulation Devices Market Size
Figure 2020-2030 North America Neuromodulation Devices Market Size and CAGR
Table 2020-2030 North America Neuromodulation Devices Market Size by Application
Table 2020-2025 North America Neuromodulation Devices Key Players Revenue
Table 2020-2025 North America Neuromodulation Devices Key Players Market Share
Table 2020-2030 North America Neuromodulation Devices Market Size by Type
Table 2020-2030 United States Neuromodulation Devices Market Size
Table 2020-2030 Canada Neuromodulation Devices Market Size
Table 2020-2030 Mexico Neuromodulation Devices Market Size
Table 2020-2030 South America Neuromodulation Devices Market Size
Figure 2020-2030 South America Neuromodulation Devices Market Size and CAGR
Table 2020-2030 South America Neuromodulation Devices Market Size by Application
Table 2020-2025 South America Neuromodulation Devices Key Players Revenue
Table 2020-2025 South America Neuromodulation Devices Key Players Market Share
Table 2020-2030 South America Neuromodulation Devices Market Size by Type
Table 2020-2030 Brazil Neuromodulation Devices Market Size
Table 2020-2030 Argentina Neuromodulation Devices Market Size
Table 2020-2030 Chile Neuromodulation Devices Market Size
Table 2020-2030 Peru Neuromodulation Devices Market Size
Table 2020-2030 Asia & Pacific Neuromodulation Devices Market Size
Figure 2020-2030 Asia & Pacific Neuromodulation Devices Market Size and CAGR
Table 2020-2030 Asia & Pacific Neuromodulation Devices Market Size by Application
Table 2020-2025 Asia & Pacific Neuromodulation Devices Key Players Revenue
Table 2020-2025 Asia & Pacific Neuromodulation Devices Key Players Market Share
Table 2020-2030 Asia & Pacific Neuromodulation Devices Market Size by Type
Table 2020-2030 China Neuromodulation Devices Market Size
Table 2020-2030 India Neuromodulation Devices Market Size
Table 2020-2030 Japan Neuromodulation Devices Market Size
Table 2020-2030 South Korea Neuromodulation Devices Market Size
Table 2020-2030 Southeast Asia Neuromodulation Devices Market Size
Table 2020-2030 Australia Neuromodulation Devices Market Size
Table 2020-2030 Europe Neuromodulation Devices Market Size
Figure 2020-2030 Europe Neuromodulation Devices Market Size and CAGR
Table 2020-2030 Europe Neuromodulation Devices Market Size by Application
Table 2020-2025 Europe Neuromodulation Devices Key Players Revenue
Table 2020-2025 Europe Neuromodulation Devices Key Players Market Share
Table 2020-2030 Europe Neuromodulation Devices Market Size by Type
Table 2020-2030 Germany Neuromodulation Devices Market Size
Table 2020-2030 France Neuromodulation Devices Market Size
Table 2020-2030 United Kingdom Neuromodulation Devices Market Size
Table 2020-2030 Italy Neuromodulation Devices Market Size
Table 2020-2030 Spain Neuromodulation Devices Market Size
Table 2020-2030 Belgium Neuromodulation Devices Market Size
Table 2020-2030 Netherlands Neuromodulation Devices Market Size
Table 2020-2030 Austria Neuromodulation Devices Market Size
Table 2020-2030 Poland Neuromodulation Devices Market Size
Table 2020-2030 Russia Neuromodulation Devices Market Size
Table 2020-2030 MEA Neuromodulation Devices Market Size
Figure 2020-2030 MEA Neuromodulation Devices Market Size and CAGR
Table 2020-2030 MEA Neuromodulation Devices Market Size by Application
Table 2020-2025 MEA Neuromodulation Devices Key Players Revenue
Table 2020-2025 MEA Neuromodulation Devices Key Players Market Share
Table 2020-2030 MEA Neuromodulation Devices Market Size by Type
Table 2020-2030 Egypt Neuromodulation Devices Market Size
Table 2020-2030 Israel Neuromodulation Devices Market Size
Table 2020-2030 South Africa Neuromodulation Devices Market Size
Table 2020-2030 Gulf Cooperation Council Countries Neuromodulation Devices Market Size
Table 2020-2030 Turkey Neuromodulation Devices Market Size
Table 2020-2025 Global Neuromodulation Devices Market Size by Region
Table 2020-2025 Global Neuromodulation Devices Market Size Share by Region
Table 2020-2025 Global Neuromodulation Devices Market Size by Application
Table 2020-2025 Global Neuromodulation Devices Market Share by Application
Table 2020-2025 Global Neuromodulation Devices Key Vendors Revenue
Figure 2020-2025 Global Neuromodulation Devices Market Size and Growth Rate
Table 2020-2025 Global Neuromodulation Devices Key Vendors Market Share
Table 2020-2025 Global Neuromodulation Devices Market Size by Type
Table 2020-2025 Global Neuromodulation Devices Market Share by Type
Table 2025-2030 Global Neuromodulation Devices Market Size by Region
Table 2025-2030 Global Neuromodulation Devices Market Size Share by Region
Table 2025-2030 Global Neuromodulation Devices Market Size by Application
Table 2025-2030 Global Neuromodulation Devices Market Share by Application
Table 2025-2030 Global Neuromodulation Devices Key Vendors Revenue
Figure 2025-2030 Global Neuromodulation Devices Market Size and Growth Rate
Table 2025-2030 Global Neuromodulation Devices Key Vendors Market Share
Table 2025-2030 Global Neuromodulation Devices Market Size by Type
Table 2025-2030 Neuromodulation Devices Global Market Share by Type

Companies Mentioned

Medtronic
Boston Scientific Corporation
Abbott
Nevro Corporation
Saluda Medical
Nexstim
LivaNova
Neuropace
ElectroCore
Axonics
Laborie
Mainstay Medical

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€3500EUR$3,997USD£3,115GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€4500EUR$5,140USD£4,005GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€5500EUR$6,282USD£4,895GBP

Market Size and Growth Forecast

Regional Analysis

Application Analysis

Type Analysis

Key Market Players

Porter's Five Forces Analysis

Market Opportunities and Challenges

Opportunities

Challenges

Table of Contents

Companies Mentioned

Related Topics

Related Reports

Neuromodulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Neuromodulation Devices Market Size, Share & Trends Analysis By Product (Spinal Cord Stimulators, Deep Brain Stimulators), By Application (Parkinson's Disease, Chronic Pain), By End-use, By Region, 2025 - 2030

Internal Neuromodulation Devices Market Report 2025

Neuromodulation Devices Market by Product, Application, End User - Global Forecast 2025-2030

Neuromodulation Market by Technology, Application - Global Forecast 2025-2030